期刊
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
卷 60, 期 1, 页码 19-37出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.critrevonc.2006.03.003
关键词
ovarian cancer; prognostic factors; omics technologies
A major problem in clinical management of patients with epithelial ovarian cancer (EOC) is the largely unpredictable response to first-line treatment and the occurrence of relapse after complete initial response, associated with broad cross-resistance to even structurally dissimilar drugs. During tumor development and progression, multiple genic alterations take place that might contribute specifically to the treatment response and eventually impact on disease outcome. One area of intense research is the identification of molecular markers to accurately assess the prognosis of EOC patients and to define innovative therapeutic strategies. A large survey of recent published data indicates the need to revisit traditional molecular markers with respect to their contribution to the assessment of overall survival in selected populations. Furthermore, recent technological developments that enable simultaneous measurement of many parameters (omic approaches) hold the promise of identifying new molecular prognostic and predictive markers. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据